New biomarker may facilitate monitoring T1D patients’ healthIncrease in PD-1+ T-cells correlated with therapeutic response and less insulin use Gdańsk, Poland – 4 April 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cellular therapies...
Related Keywords
Poland , Piotr Trzonkowski , Poltreg Sa Warsaw Stock Exchange , International Immunopharmacology , Warsaw Stock Exchange ,
comparemela.com © 2020. All Rights Reserved.